SRC="/isubscribe/journals/joceah/72/i07/figures/jo062007qn00002.gif" ALIGN="left" HSPACE=5> |
The di
stribution of the P2X
7 receptor in inflammatory cell
s sugge
st
s that P2X
7 antagoni
st
s have a
significantrole to play in the treatment of inflammatory di
sea
se. We conducted a natural product high-throughput
screening campaign to di
scover P2X
7 receptor antagoni
st
s. The Au
stralian marine
sponge
Stylissa flabellatayielded two new bi
simidazo-pyrano-imidazole bromopyrrole ether alkaloid
s,
styli
ssadine
s A (IC
50 0.7
![](/image<font color=)
s/entitie
s/mgr.gif">M) and B (IC
50 1.8
![](/image<font color=)
s/entitie
s/mgr.gif">M), a
s the
specific bioactive con
stituent
s. The compound
s inhibit BzATP-mediatedpore formation in THP-1 cell
s. Al
so pre
sent in thi
s extract wa
s con
siderable non
specific bioactivity inthe hemeoly
sin
specificity a
ssay. A new pyrrole-imidazole alkaloid, konbu'acidin B, and the knownpyrrole-imidazole alkaloid
s 4,5-dibromopalau'amine and ma
ssadine were al
so i
solated and had non
specificactivity. ROESY and proton coupling con
stant data indicated that the
stereochemi
stry at C12, C17, andC20 in 4,5-dibromopalau'amine
should be revi
sed to 12
R, 17
S, 20
S. By analogy, the relative
stereochemi
stry of palau'amine, 4-bromopalau'amine,
styloguanidine, 3-bromo
styloguanidine, and 2,3-dibromo
styloguanidine
should al
so be revi
sed to 12
R, 17
S, 20
S. Styli
ssadine
s A and B are the mo
stpotent natural product P2X
7 antagoni
st
s to be i
solated to date and provide a novel cla
ss of P2X
7 receptorinhibitor
s. They are al
so the fir
st example
s of tetrameric pyrrole-imidazole alkaloid
s.